13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001569064
Total reported value
$5.5B
$5.5B
98 檔
16.0%
During the Q2 2024 filing period, Montanova Capital, LLC (CIK: 0001569064) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $5.5B across 98 reported positions.
Montanova Capital, LLC executed strategic sector rebalancing during Q2 2024, establishing 7 new positions while fully exiting 10 holdings and trimming 13 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 10.00% | +7.16% | +11.11% | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 6.63% | +0.58% | +29.88% | |
| 3 | INSM | Insmed Inc | Stock-Healthcare | 6.21% | — | +24.66% | |
| 4 | KURA | Kura Oncology Inc | Stock-Other | 5.35% | -0.06% | — | |
| 5 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 3.94% | — | +63.26% | |
| 6 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 3.42% | -1.46% | +27.00% | |
| 7 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 3.11% | — | +22.94% | |
| 8 | META | Meta Platforms Inc-class A | Stock-Comm Services | 3.10% | -0.67% | -3.71% | |
| 9 | ACLXGBX | Arcellx Inc | Stock-Other | 3.07% | — | -2.95% | |
| 10 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 3.02% | -0.21% | +967.70% | |
| 11 | AAPL | Apple Inc | Stock-Tech | 2.81% | — | +105.66% | |
| 12 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 2.53% | -0.46% | -0.19% | |
| 13 | ETNBGBP | 89bio Inc | Stock-Other | 2.36% | — | +27.53% | |
| 14 | TSM | Taiwan Semiconductor-sp Adr | Stock-Tech | 2.24% | +0.08% | +6.50% | |
| 15 | AMD | Advanced Micro Devices | Stock-Tech | 2.06% | +1.39% | +1.26% | |
| 16 | ELV | Elevance Health Inc | Stock-Healthcare | 1.82% | — | +79.56% | |
| 17 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 1.81% | -2.45% | EXIT | |
| 18 | RPRX | Royalty Pharma plc | Stock-Healthcare | 1.81% | — | -17.06% | |
| 19 | MSFT | Microsoft CORP | Stock-Tech | 1.71% | -0.02% | +31.16% | |
| 20 | EYPT | Eyepoint Inc | Stock-Other | 1.65% | -0.56% | +37.51% | |
| 21 | APO | Apollo Global Management Inc | Stock-Financials | 1.54% | -0.27% | -4.36% | |
| 22 | T | At&t Inc | Stock-Comm Services | 1.54% | — | -8.83% | |
| 23 | SYY | Sysco CORP | Stock-Consumer Staples | 1.37% | +0.05% | — | |
| 24 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 1.33% | -0.10% | — | |
| 25 | KO | Coca-cola Co/the | Stock-Consumer Staples | 1.31% | — | +2.58% | |
| 26 | GS | Goldman Sachs Group Inc | Stock-Financials | 1.30% | — | -29.07% | |
| 27 | ORCL | Oracle CORP | Stock-Tech | 1.27% | — | +24.63% | |
| 28 | GE | General Electric | Stock-Industrials | 1.20% | -0.13% | -1.20% | |
| 29 | ERAS | Erasca Inc | Stock-Other | 1.19% | -1.42% | EXIT | |
| 30 | CRH | CRH plc | Stock-Materials | 1.19% | — | +28.73% | |
| 31 | AVBP | Arrivent Biopharma Inc | Stock-Other | 1.17% | +0.28% | +9.53% | |
| 32 | MCD | Mcdonald's CORP | Stock-Consumer Disc | 1.03% | — | — | |
| 33 | FERG | Ferguson Enterprises Inc. | Stock-Industrials | 1.03% | — | -14.32% | |
| 34 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.98% | -0.05% | EXIT | |
| 35 | VZ | Verizon Communications Inc | Stock-Comm Services | 0.92% | — | -48.29% | |
| 36 | CMG | Chipotle Mexican Grill Inc | Stock-Consumer Disc | 0.92% | — | +4900.00% | |
| 37 | PEPG | Pepgen Inc | Stock-Other | 0.89% | — | — | |
| 38 | ✓ | Prokidney CORP | Stock-Other | 0.84% | — | +141.51% | |
| 39 | STRO | Sutro Biopharma, Inc. | Stock-Other | 0.83% | — | +33.41% | |
| 40 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.71% | -0.09% | -16.94% | |
| 41 | PINS | Pinterest Inc- Class A | Stock-Comm Services | 0.66% | — | +3.56% | |
| 42 | ✓ | Zura Bio LTD | Stock-Other | 0.62% | -0.36% | +70.56% | |
| 43 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 0.58% | -1.04% | -10.79% | |
| 44 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.57% | -0.25% | — | |
| 45 | RCUS | Arcus Biosciences Inc | Stock-Other | 0.54% | -0.09% | — | |
| 46 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.48% | -0.11% | — | |
| 47 | BNTC | Benitec Biopharma Inc | Stock-Other | 0.43% | -0.31% | +728.17% | |
| 48 | ✓ | Immatics NV | Stock-Other | 0.40% | -0.74% | — | |
| 49 | SNY | Sanofi-adr | Stock-Healthcare | 0.38% | — | — | |
| 50 | IFRX | InflaRx N.V. | Stock-Other | 0.37% | +0.76% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | +4.2% | +24.66% | Add |
| 2 | UNH | Unitedhealth Group Inc | +2.7% | +967.70% | Add |
| 3 | AAPL | Apple Inc | +1.7% | +105.66% | Add |
| 4 | ITCIEUR | Intra-cellular Therapies Inc | +1.5% | +63.26% | Add |
| 5 | SYY | Sysco CORP | +1.4% | NEW | New buy |
| 6 | CTNM | Contineum Therapeutics Inc-a | +1.3% | NEW | New buy |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | +1.3% | +11.11% | Add |
| 8 | ERAS | Erasca Inc | +1.2% | NEW | New buy |
| 9 | MCD | Mcdonald's CORP | +1% | NEW | New buy |
| 10 | TSLA | Tesla Inc | +1% | NEW | New buy |
| 11 | ELV | Elevance Health Inc | +0.8% | +79.56% | Add |
| 12 | ✓ | Prokidney CORP | +0.6% | +141.51% | Add |
| 13 | TSM | Taiwan Semiconductor-sp Adr | +0.6% | +6.50% | Add |
| 14 | ABEO | Abeona Therapeutics Inc | +0.6% | NEW | New buy |
| 15 | ARQT | Arcutis Biotherapeutics Inc | +0.5% | +27.00% | Add |
| 16 | MSFT | Microsoft CORP | +0.5% | +31.16% | Add |
| 17 | BNTC | Benitec Biopharma Inc | +0.4% | +728.17% | Add |
| 18 | GLUE | Monte Rosa Therapeutics Inc | +0.4% | NEW | New buy |
| 19 | ORCL | Oracle CORP | +0.4% | +24.63% | Add |
| 20 | ✓ | Zura Bio LTD | +0.4% | +70.56% | Add |
| 21 | RARE | Ultragenyx Pharmaceutical In | +0.2% | +22.94% | Add |
| 22 | AMZN | Amazon.com Inc | +0.1% | -0.19% | Trim |
| 23 | ELAN | Elanco Animal Health Inc | -0.2% | -50.00% | Trim |
| 24 | AMD | Advanced Micro Devices | -0.2% | +1.26% | Add |
| 25 | KRRO | Korro Bio Inc | -0.3% | EXIT | Sold out |
| 26 | KURA | Kura Oncology Inc | -0.3% | — | Unchanged |
| 27 | RVNCEUR | Revance Therapeutics Inc | -0.3% | -96.35% | Trim |
| 28 | 430 | Terns Pharmaceuticals Inc | -0.3% | EXIT | Sold out |
| 29 | FERG | Ferguson Enterprises Inc. | -0.3% | -14.32% | Trim |
| 30 | ETNBGBP | 89bio Inc | -0.4% | +27.53% | Add |
| 31 | STRO | Sutro Biopharma, Inc. | -0.4% | +33.41% | Add |
| 32 | GS | Goldman Sachs Group Inc | -0.4% | -29.07% | Trim |
| 33 | FULC | Fulcrum Therapeutics Inc | -0.4% | -10.79% | Trim |
| 34 | MREO | Mereo Biopharma Group Pl-adr | -0.4% | -97.95% | Trim |
| 35 | GPN | Global Payments Inc | -0.5% | EXIT | Sold out |
| 36 | SBUX | Starbucks CORP | -0.6% | EXIT | Sold out |
| 37 | HLT | Hilton Worldwide Holdings In | -0.6% | EXIT | Sold out |
| 38 | CRM | Salesforce Inc | -0.6% | EXIT | Sold out |
| 39 | FATE | Fate Therapeutics Inc | -0.7% | EXIT | Sold out |
| 40 | RPRX | Royalty Pharma plc | -0.7% | -17.06% | Trim |
| 41 | BCYC | Bicycle Therapeutics Plc-adr | -0.9% | EXIT | Sold out |
| 42 | VZ | Verizon Communications Inc | -0.9% | -48.29% | Trim |
| 43 | ACLXGBX | Arcellx Inc | -1% | -2.95% | Trim |
| 44 | MCK | Mckesson CORP | -1.1% | -96.77% | Trim |
| 45 | EYPT | Eyepoint Inc | -1.2% | +37.51% | Add |
| 46 | BHVN | Biohaven Ltd. | -1.5% | +29.88% | Add |
| 47 | MRNS* | Marinus Pharmaceuticals Inc | -1.6% | -25.22% | Trim |
| 48 | ARGX | Argenx Se - Adr | -1.8% | EXIT | Sold out |
| 49 | CI | THE Cigna Group | -1.8% | -96.50% | Trim |
| 50 | QQQ | Invesco Qqq Trust Series 1 | -3.2% | EXIT | Sold out |
According to official SEC Form 13F filings, Montanova Capital, LLC reported a total U.S. public equity portfolio value of $5.5B across 98 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, BHVN, INSM) accounted for 16.0% of total reported equity market value during Q2 2024.
Top New Position Initiated
SYY
市值: $37.2M
Top Position Liquidated / Trimmed
QQQ
前期市值: $86.6M
During Q2 2024, Montanova Capital, LLC's top holdings by market value included SPY (10.0%)、BHVN (6.6%)、INSM (6.2%). The largest single position, SPY, represented 10.0% of total portfolio value.
In Q2 2024, Montanova Capital, LLC made 49 total portfolio adjustments, initiating 7 new buys, adding to 19 positions, trimming 13 holdings, and fully liquidating 10 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.